These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31060489)

  • 1. Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review.
    Zhang W; Zhao T; Zhao Y; Gui D; Xu Y
    Curr Vasc Pharmacol; 2020; 18(4):322-333. PubMed ID: 31060489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
    Fei J; Ling YM; Zeng MJ; Zhang KW
    Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-aptamers raised against AGEs as a blocker of various aging-related disorders.
    Yamagishi S; Taguchi K; Fukami K
    Glycoconj J; 2016 Aug; 33(4):683-90. PubMed ID: 27338620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive treatment of traditional Chinese medicine as antistress and antiaging strategy.
    Liang ZH; Yin DZ
    Rejuvenation Res; 2010; 13(2-3):248-52. PubMed ID: 19954331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does accumulation of advanced glycation end products contribute to the aging phenotype?
    Semba RD; Nicklett EJ; Ferrucci L
    J Gerontol A Biol Sci Med Sci; 2010 Sep; 65(9):963-75. PubMed ID: 20478906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Glycation End Products: A Molecular Target for Vascular Complications in Diabetes.
    Yamagishi S; Nakamura N; Suematsu M; Kaseda K; Matsui T
    Mol Med; 2015 Oct; 21 Suppl 1(Suppl 1):S32-40. PubMed ID: 26605646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
    Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
    Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
    Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
    Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis.
    Trellu S; Courties A; Jaisson S; Gorisse L; Gillery P; Kerdine-Römer S; Vaamonde-Garcia C; Houard X; Ekhirch FP; Sautet A; Friguet B; Jacques C; Berenbaum F; Sellam J
    Arthritis Res Ther; 2019 Jan; 21(1):18. PubMed ID: 30635030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products, diabetes and ageing.
    Nass N; Bartling B; Navarrete Santos A; Scheubel RJ; Börgermann J; Silber RE; Simm A
    Z Gerontol Geriatr; 2007 Oct; 40(5):349-56. PubMed ID: 17943238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of glycation inhibitors on aging and age-related diseases.
    Sadowska-Bartosz I; Bartosz G
    Mech Ageing Dev; 2016 Dec; 160():1-18. PubMed ID: 27671971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosslink breakers: a new approach to cardiovascular therapy.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Curr Opin Cardiol; 2004 Jul; 19(4):336-40. PubMed ID: 15218393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical/Translational Aspects of Advanced Glycation End-Products.
    Zeng C; Li Y; Ma J; Niu L; Tay FR
    Trends Endocrinol Metab; 2019 Dec; 30(12):959-973. PubMed ID: 31597608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products and insulin resistance.
    Unoki H; Yamagishi S
    Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iridoids are natural glycation inhibitors.
    West BJ; Deng S; Uwaya A; Isami F; Abe Y; Yamagishi S; Jensen CJ
    Glycoconj J; 2016 Aug; 33(4):671-81. PubMed ID: 27306206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease.
    Takeuchi M; Yamagishi S
    Curr Pharm Des; 2008; 14(10):973-8. PubMed ID: 18473848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of resveratrol on toxicity and related complications of advanced glycation end products: A systematic review.
    Hajizadeh-Sharafabad F; Sahebkar A; Zabetian-Targhi F; Maleki V
    Biofactors; 2019 Sep; 45(5):651-665. PubMed ID: 31185146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products (AGEs) and other adducts in aging-related diseases and alcohol-mediated tissue injury.
    Rungratanawanich W; Qu Y; Wang X; Essa MM; Song BJ
    Exp Mol Med; 2021 Feb; 53(2):168-188. PubMed ID: 33568752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and Causality.
    Chaudhuri J; Bains Y; Guha S; Kahn A; Hall D; Bose N; Gugliucci A; Kapahi P
    Cell Metab; 2018 Sep; 28(3):337-352. PubMed ID: 30184484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases.
    Byun K; Yoo Y; Son M; Lee J; Jeong GB; Park YM; Salekdeh GH; Lee B
    Pharmacol Ther; 2017 Sep; 177():44-55. PubMed ID: 28223234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.